 | | | | Related Healthscout Videos | |
|
THURSDAY, Sept. 21 (HealthDay News) -- While more kidney cancers are being diagnosed and treated early, the number of deaths from the disease continues to increase, University of Michigan researchers report.
The fact that the number of cases has been growing is largely due to the detection of small, presumably curable, tumors, so the scientists said they aren't exactly sure why so many are still dying.
Text Continues Below
However, one expert noted the trend might be explained by the lack of effective chemotherapy drugs to give kidney cancer patients once they have had surgery to remove tumors.
Kidney cancer is the third most common cancer of the reproductive and urinary systems. There will be some 38,890 new cases of kidney cancer in the United States this year, and some 12,840 people will die from the disease, the American Cancer Society estimates.
The latest research was published in the Sept. 20 issue of the Journal of the National Cancer Institute.
"With increased early detection and treatment of small tumors, we would expect to see a decrease in mortality associated with kidney cancer," study senior author Dr. Brent K. Hollenbeck said in a statement. "Surprisingly, that's not what we found. Our research shows that an increase in detection and treatment is not leading to a reduction in the kidney cancer mortality rate."
In the study, Hollenbeck's team collected data on 34,503 patients who had kidney cancer.
They found that from 1983 to 2002, the incidence of kidney cancer increased 52 percent, from 7.1 to 10.8 cases per 100,000 people. The biggest increase was seen in the number of people with small tumors, roughly 2 centimeters to 4 centimeters in size.
However, death rates also went up, most notably among those with tumors larger than 7 centimeters. Overall, deaths from kidney cancer rose from 1.2 to 3.2 per 100,000 people, the researchers noted.
Page: 1 | 2 | Next >>
|
.gif)
